0001415889-23-014037.txt : 20231006
0001415889-23-014037.hdr.sgml : 20231006
20231006162641
ACCESSION NUMBER: 0001415889-23-014037
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231004
FILED AS OF DATE: 20231006
DATE AS OF CHANGE: 20231006
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Megna Michael R
CENTRAL INDEX KEY: 0001464583
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38492
FILM NUMBER: 231314514
MAIL ADDRESS:
STREET 1: 1050 HINGHAM STREET
CITY: ROCKLAND
STATE: MA
ZIP: 02370
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Kiniksa Pharmaceuticals, Ltd.
CENTRAL INDEX KEY: 0001730430
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: D0
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: CLARENDON HOUSE
STREET 2: 2 CHURCH STREET
CITY: HAMILTON
STATE: D0
ZIP: HM11
BUSINESS PHONE: 7814399100
MAIL ADDRESS:
STREET 1: CLARENDON HOUSE
STREET 2: 2 CHURCH STREET
CITY: HAMILTON
STATE: D0
ZIP: HM11
4
1
form4-10062023_081034.xml
X0508
4
2023-10-04
0001730430
Kiniksa Pharmaceuticals, Ltd.
KNSA
0001464583
Megna Michael R
C/O KINIKSA PHARMACEUTICALS, LTD.
CLARENDON HOUSE 2 CHURCH STREET
HAMILTON
D0
HM 11
BERMUDA
false
true
false
false
CHIEF ACCOUNTING OFFICER
0
Class A Common Share
2023-10-04
4
M
0
175
A
17057
D
Class A Common Share
2023-10-04
4
F
0
52
16.01
D
17005
D
Restricted Share Unit
2023-10-04
4
M
0
175
0
D
Class A Common Share
175
350
D
Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Common Share of the Issuer.
The RSUs vest over a four year period, with 25% of the RSUs vesting on each anniversary of the date of grant, October 4, 2021.
/s/ Madelyn Zeylikman, Attorney-in-Fact
2023-10-06